Gavin Hattersley
Gavin Hattersley's purchase track record
Gavin Hattersley has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/2/2026 | MKC | $45K | pending | pending | — |
| 4/10/2026 | MKC | $106K | -0.6% | -15.1% | +14.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Goldman Sachs initiates Zoetis coverage with Neutral rating. Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Molson Coors Faces Lower Price Target After Q2 Earnings. Wells Fargo lowered its price target for Molson Coors to $38 and maintained an Equal-Weight rating following the company's second-quarter results. The stock is currently trading near its support level, with an RSI of 37.8 indicating recent weakness. While the average analyst target remains higher at $45.24, this specific downgrade highlights ongoing caution among some investors regarding the company's near-term outlook.
Transaction History
| MKC | ▲ Buy | Open Market | 1,000 | $45K | 10/2/2026 | View on chart |
| MKC | ▲ Buy | Open Market | 2,000 | $106K | 4/10/2026 | View on chart |
| ZTS | ▼ Sell | Other | 481 | $61K | 2/19/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,619 | — | 2/19/2026 | View on chart |
| MKC | ▲ Buy | Grant | 406 | $25K | 2/1/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,451 | — | 4/1/2025 | View on chart |
| TAP | ▲ Buy | Grant | 37,943 | $0 | 3/5/2025 | View on chart |
| TAP | ▼ Sell | Tax Withholding | 12,686 | $778K | 2/28/2025 | View on chart |
| TAP | ▲ Buy | Grant | 93,907 | $0 | 2/28/2025 | View on chart |
| TAP | ▼ Sell | Tax Withholding | 44,137 | $2.7M | 2/28/2025 | View on chart |
| TAP | ▲ Buy | Grant | 30,077 | $0 | 3/4/2024 | View on chart |
| TAP | ▼ Sell | Tax Withholding | 13,890 | $863K | 3/2/2024 | View on chart |
| TAP | ▲ Buy | Grant | 87,882 | $0 | 3/2/2024 | View on chart |
| TAP | ▼ Sell | Tax Withholding | 41,305 | $2.6M | 3/2/2024 | View on chart |
| TAP | ▼ Sell | Tax Withholding | 9,508 | $507K | 3/2/2023 | View on chart |
| TAP | ▲ Buy | Grant | 37,256 | $0 | 2/27/2023 | View on chart |
| TAP | ▼ Sell | Tax Withholding | 3,925 | $200K | 3/5/2022 | View on chart |
| TAP | ▼ Sell | Tax Withholding | 1,671 | $85K | 3/5/2022 | View on chart |
| TAP | ▲ Buy | Grant | 32,197 | $0 | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
McCormick Analysts Lower Targets After Q3 Results
McCormick shares have come under pressure as several analysts, including UBS and TD Cowen, lowered their price targets following third-quarter results. While BNP Paribas maintained a positive outlook, the broader trend reflects reduced expectations for near-term growth. The company has also replaced its auditor with KPMG and reaffirmed its overall financial outlook despite the recent stock decline.
McCormick Analysts Lower Targets After Q3 Results. McCormick shares have come under pressure as several analysts, including UBS and TD Cowen, lowered their price targets following third-quarter results. While BNP Paribas maintained a positive outlook, the broader trend reflects reduced expectations for near-term growth. The company has also replaced its auditor with KPMG and reaffirmed its overall financial outlook despite the recent stock decline.